Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes

<p>Background: The burden of vascular diseases remains substantial in patients with type 2 diabetes, requiring identification of further risk markers. We tested the absence of dorsalis pedis and posterior tibial pulses as predictors of major macrovascular and microvascular events, death, and c...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Mohammedi, K, Woodward, M, Zoungas, S, Q, L, Harrap, Stephen, S, Patel, A, Marre, M, Chalmers, J
Formaat:	Journal article
Gepubliceerd in:	American Diabetes Association 2016

Gelijkaardige items

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
door: Mohammedi, K, et al.
Gepubliceerd in: (2016)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
door: Woodward, M, et al.
Gepubliceerd in: (2016)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
door: Mohammedi, K, et al.
Gepubliceerd in: (2017)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
door: Blomster, J, et al.
Gepubliceerd in: (2017)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
door: Zoungas, S, et al.
Gepubliceerd in: (2012)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
door: Patel, A, et al.
Gepubliceerd in: (2008)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON
door: Jun, M, et al.
Gepubliceerd in: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
door: Jun, M, et al.
Gepubliceerd in: (2017)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
door: Perkovic, V, et al.
Gepubliceerd in: (2013)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
door: Ohkuma, T, et al.
Gepubliceerd in: (2018)

PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.
door: Hamet, P, et al.
Gepubliceerd in: (2017)

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
door: Clarke, P, et al.
Gepubliceerd in: (2010)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
door: Woodward, M, et al.
Gepubliceerd in: (2016)

Microvascular outcomes in type 2 diabetes - Authors' reply
door: Zoungas, S, et al.
Gepubliceerd in: (2017)

Severe Hypoglycemia and Risks of Vascular Events and Death
door: Zoungas, S, et al.
Gepubliceerd in: (2010)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
door: Mohammedi, K, et al.
Gepubliceerd in: (2018)

The relationship between plasma 8-OH-deoxyguanosine and cardiovascular disease and survival in type 2 diabetes: results from the ADVANCE study
door: Thomas, M, et al.
Gepubliceerd in: (2018)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
door: Zoungas, S, et al.
Gepubliceerd in: (2009)

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
door: Heart Protection Study Collaborative Group
Gepubliceerd in: (2007)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
door: Ohkuma, T, et al.
Gepubliceerd in: (2017)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
door: Rahman, F, et al.
Gepubliceerd in: (2019)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
door: Ohkuma, T, et al.
Gepubliceerd in: (2019)

Plasma fatty acids and the risk of vascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study
door: Harris, K, et al.
Gepubliceerd in: (2020)

EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes
door: Zhang, Z, et al.
Gepubliceerd in: (2019)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
door: Welsh, P, et al.
Gepubliceerd in: (2018)

The effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
door: Zoungas, S, et al.
Gepubliceerd in: (2017)

Intensive glucose control and macrovascular outcomes in type 2 diabetes.
door: Turnbull, F, et al.
Gepubliceerd in: (2009)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
door: Patel, A, et al.
Gepubliceerd in: (2007)

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.
door: Adler, A, et al.
Gepubliceerd in: (2002)

Population-based Study of Event-rate, Incidence, and Outcome for Peripheral Vascular Events: The Oxford Vascular Study
door: Banerjee, A, et al.
Gepubliceerd in: (2009)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
door: van Steen, S, et al.
Gepubliceerd in: (2018)

Lowering blood pressure reduces renal events in type 2 diabetes.
door: de Galan, B, et al.
Gepubliceerd in: (2009)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
door: Hata, J, et al.
Gepubliceerd in: (2012)

Hypercoagulability predicts poor outcome from coronary intervention in patients with peripheral vascular disease
door: Sleight, S, et al.
Gepubliceerd in: (2003)

In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes
door: Ng, SYA, et al.
Gepubliceerd in: (2020)

Absence of Chlamydia pneumoniae in brain of vascular dementia patients.
door: Wozniak, M, et al.
Gepubliceerd in: (2003)

Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study.
door: Morton, J, et al.
Gepubliceerd in: (2012)

Peripheral vascular ultrasound : how, why, and when /
door: 346114 Thrush, Abigail, et al.
Gepubliceerd in: (2005)

Glycaemia and vascular effects of type 2 diabetes - Reply
door: Stratton, I, et al.
Gepubliceerd in: (2001)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
door: Rådholm, K, et al.
Gepubliceerd in: (2018)